The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease

Author： Heitsch Holger  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.5, 2003-05, pp. : 759-770

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-peptide Antagonists and Agonists of the Bradykinin B2 Receptor

By  

Current Medicinal Chemistry, Vol. 9, Iss. 9, 2002-05 ,pp. : 913-928

Bentham Science Publishers

Access to resources Recommend Favorite

5-HT2C Receptor Agonists as Potential Drugs for the Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 8, 2003-05 ,pp. : 885-897

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of the Cannabinoid CB2 Receptor in Pain Transmission and Therapeutic Potential of Small Molecule CB2 Receptor Agonists

By  

Current Medicinal Chemistry, Vol. 14, Iss. 8, 2007-04 ,pp. : 917-936

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of melatonin receptor agonists and antagonists

By Dubocovich M.L.  

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 153-173

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of cannabinoid receptor agonists as analgesic agents

By Fox Alyson   Bevan Stuart  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 695-703

Informa Healthcare

Access to resources Recommend Favorite